Study identifies biomarker and potential therapy target in multiple sclerosis
Researchers from Benaroya Research Institute at Virginia Mason (BRI) have found that proteins in the IL-6 signaling pathway may be leveraged as novel biomarkers of multiple sclerosis (MS) to gauge disease activity and as ...
Jan 30, 2013
0
0